Latest revenue
$6.2M
as of 2025-09-30
Latest net income
$-3.2M
as of 2025-09-30
Net margin
-51.2%
as of 2025-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $19.8M
- Enterprise value
- $19.8M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $7.69
- 52-wk low
- $0.35
- Beta
- —
- Shares out
- 2.8M
5-year trend
What this company does
ITEM 1. BUSINESS Overview We are a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury (“SCI Products”). These devices are robotic exoskeletons that are designed for individuals with paraplegia that use our patented tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. These SCI…
AI summary unavailable — showing raw filing excerpt
Generated from LFWD's filing dated 2026-03-18
Key risks
ITEM 1A. RISK FACTORS Our business faces significant risks. You should carefully consider all of the information set forth in this annual report and in our other filings with the SEC, including the following risk factors which we face and which are faced by our industry. Our business, financial condition and results of operations could be materially and adversely affected by any of these risks. In that event, the trading price of our ordinary shares would likely decline and you might lose all or part of your investment. This report also contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these…
AI summary unavailable — showing raw filing excerpt
Generated from LFWD's filing dated 2026-03-18
Profitability
Gross margin
38.2%
19.5%Operating margin
-89.3%
21.9%Net margin
-90.4%
19.9%Return on equity
-236.8%
54.3%Return on assets
-87.0%
8.4%Leverage
Debt / equity
1.72×
179.2%Debt / assets
63.3%
65.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q4 2025 2025-12-31 | $5.1M | -32.7% | $-5.3M | +65.0% | -105.3% |
Q3 2025 2025-09-30 | $6.2M | +1.1% | $-3.2M | -2.8% | -51.2% |
Q2 2025 2025-06-30 | $5.7M | -14.7% | $-6.6M | -52.5% | -114.6% |
Q1 2025 2025-03-31 | $5.0M | -4.7% | $-4.8M | +23.0% | -96.0% |
Q4 2024 2024-12-31 | $7.5M | — | $-15.3M | — | -202.5% |
Q3 2024 2024-09-30 | $6.1M | +39.2% | $-3.1M | +59.0% | -50.3% |
Q2 2024 2024-06-30 | $6.7M | +401.6% | $-4.3M | +7.3% | -64.2% |
Q1 2024 2024-03-31 | $5.3M | — | $-6.3M | — | -118.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842
Your notes
Keep private notes on LFWD — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$1.0K
Net activity
−$1.0K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2025-09-02 | Jeannine Lynch VP of Market Access & Strategy | Sale | 1,591 | $0.64 | $1.0K |
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns LFWD
Institutional value
$15.4K
Total shares held
2.3K
Distinct holders
4
-16 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 2.1K | $14.1K | -17.0K (-88.9%) | Trimmed |
| 2 | SBI Securities Co., Ltd. | 196 | $1.3K | -2.1K (-91.5%) | Trimmed |
| 3 | Caitong International Asset Management Co., Ltd | 4 | $27 | — | New |
| 4 | GROUP ONE TRADING LLC | 2 | $13 | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once LFWD's latest filing finishes processing.